Quasar Bio-Tech, Inc
FDA inspection history across 2 sites, 2011 to 2024
- 1
- Form 483
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2011: one warning letter; 2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2011One warning letter, at Sarasota, Florida.
- 2024One Form 483, at Yorba Linda, California.
Cited most
Across all Quasar Bio-Tech observations on file
- 21 CFR 820.198(a)Complaint files1
- 21 CFR 820.22Quality audit1
- 21 CFR 820.40Document controls1
- 21 CFR 820.50(b)Purchasing controls1
The complete Quasar Bio-Tech file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Yorba Linda, California
One Form 483 · 2024 · 4 observations
Latest: Form 483, Dec 20, 2024 →Sarasota, Florida
One warning letter · 2011
Latest: Warning letter, Dec 9, 2011 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-12-20 | 483 Form 483 | Yorba Linda, California | 4 | $99 |
| 2011-12-09 | Warning letter Warning letter | Sarasota, Florida | — | $99 |
Investigators on these documents
FEI number 3006182559 · most recent document Dec 20, 2024
About Quasar Bio-Tech, Inc
How many FDA Form 483s has Quasar Bio-Tech, Inc received?
FDA Intel has 1 Form 483 on file for Quasar Bio-Tech, Inc; the most recent is dated Dec 20, 2024.
When was Quasar Bio-Tech, Inc last inspected by FDA?
The most recent FDA inspection document on file for Quasar Bio-Tech, Inc is a Form 483 dated Dec 20, 2024, for the site in Yorba Linda, California.
What did FDA cite at Quasar Bio-Tech, Inc?
The regulations cited most in the observations on file for Quasar Bio-Tech, Inc are 21 CFR 820.198(a) (Complaint files), 1 time; 21 CFR 820.22 (Quality audit), 1 time; 21 CFR 820.40 (Document controls), 1 time.
Has Quasar Bio-Tech, Inc received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Quasar Bio-Tech, Inc; the most recent is dated Dec 9, 2011.